中西医结合治疗子宫内膜异位症临床研究被引量：25

在线阅读下载PDF

导出

摘要目的探讨中西医结合方法治疗子宫内膜异位症的临床疗效。方法采用中药保留灌肠,中药离子导入加口服孕三烯酮、散结镇痛胶囊治疗子宫内膜异位症患者36例。结果本组治愈10例(28%),显效13例(36%),有效8例(22%),无效5例(14%),总有效率86%。8例抗子宫内膜抗体阳性者治疗后全部转阴,8例不孕患者治愈停药1 a,有2例受孕。结论中西医结合治疗子宫内膜异位症有较好的疗效,值得临床推广。

作者毕景芹薄国荣赵华兴杨元

机构地区河北省围场满族蒙古族自治县医院

出处《现代中西医结合杂志》 CAS 2013年第11期1162-1164,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine

关键词孕三烯酮散结镇痛胶囊中药灌肠离子导入子宫内膜异位症

分类号 R711.32 [医药卫生—妇产科学]

引文网络
相关文献

参考文献22

1郎景和.子宫内膜异位症的研究与设想[J].中华妇产科杂志,2003,38(8):478-480. 被引量：530
2彭薇萍.中西医结合治疗子宫内膜异位症32例临床观察[J].中华中西医杂志,2005,6(12) :26-27.
3王曼,俞瑾,钱祖淇.子宫内膜异位症、妊娠高血压综合征及女性不孕症的中西医结合诊疗标准[J].中西医结合杂志,1991,11(6):376-379. 被引量：582
4刘义,郎景和.子宫内膜异位症的恶变[M]//曹泽毅.中华妇产科学.2版.北京:人民卫生出版社,2004:1481 -1486.
5Prowse AH, Manek S, Varma H, et al. Molecular genetic evidencethat endometriosis is a precursor of ovarian cancer[ J ]. Int J Canc-er ,2006 ,119 (3) :556 -562.
6Korner M,Burckhardt E,Mazzucchelli L. Higher frequency of chro-mosomal aberrations in ovarian endometriosis compared to extrago-nadal endometriosis : a possible link to endometrioid adenocarcinoma[J]. Mod Pathol,2006,19(12) ;1615 -1623.
7Akahane T,Sekizawa A,Purwosunu Y,et al. The role of p53 muta-tion in the carcinomas arising from endometriosis [ J ]. Int J GynecolPathol, 2007,26 (3 ) : 345 - 351.
8柯小宁,康山,宋俊芬.子宫内膜异位症遗传与基因的研究现状[J].国外医学（遗传学分册）,2004,27(5):307-309. 被引量：2
9Yagyu T,Tsuji Y, Haruta S,et al. Activation of mammalian target ofrapamycin in postmenopausal ovarian endometriosis [ J ]. Int J Gyne-col Cancer,2006,16(4) :1545 - 1551.
10冷金花,郎景和.子宫内膜异位症的恶变[M]//曹泽毅.中华妇产科学.2版.北京:人民卫生出版社,2004:1518 -1522.

二级参考文献56

1江森.子宫内膜异位症研究的进展[J].中华妇产科杂志,1994,29(10):624-627. 被引量：65
2刘义,郎景和.子宫内膜异位症的发病机制和病理生理学∥曹泽毅.中华妇产科学.2版.北京:人民卫生出社,2004:1477-1485.
3Prfumo F,Todeschini F,Fulcheri E,et al.Epithelial abnormalities in cyatic ovarian codometriosis.Gynecol Oncol,2002,84:280-284.
4Ogawa S,Kaku T,Amada S,et al.Ovarian endometriosis associated with ovarian carcinoma:a diniopathological and immunohistochemical study.Gynecol Oncol,2000,77:298-304.
5Laceyjr.JV,Mink PJ,Lubin JH,et al.Menopausal hormone replacement therapy and risk of ovarian cancer.J Am Med Association,2002,288:334-341.
6Nomura SJ,Suganuma TY,Suzuki TH,et al.Endometrioid adenocarcinoma arising from endometriosis during 2 years of estrogen replacement therapy after total hysterectomy and bilateral salpingooophorectomy.Acts Obstet Gynecol Scand,2006,85:1019-1021.
7Zanetta GM,Webb MJ,Li H,et al.Hyperestrogenism:a relevant risk factor for the development of cancer from endometriosis.Gynecol Oncol,2000,79:18-22.
8Scott M.Endometrioid adenocarcinomas of the ovary and its relationship to endometriosis.Gynecol Oncol,1995,59:81-86.
9Kumiyama S.Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis cliniopathologic evaluation.Gynecol Oncol,1991,72:342-346.
10小西郁生,伊东和子,堀内晶子.内膜症を母地とすゐ卵巢癌の特徵と予後.临妇产,2006,60:134-139.